|
|
Volumn 40, Issue 3, 1999, Pages 135-142
|
|
Fungal infection in patients with serious disease. Risk analysis of fungal infection
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
BETA 1,3 GLUCAN;
BETA GLUCAN;
BETA-1,3-GLUCAN;
BIOLOGICAL MARKER;
GLUCAN;
ARTIFICIAL VENTILATION;
BLOOD;
FUNGUS;
HOSPITALIZATION;
HUMAN;
IMMUNE DEFICIENCY;
INTENSIVE CARE UNIT;
ISOLATION AND PURIFICATION;
LENGTH OF STAY;
MYCOSIS;
REVIEW;
RISK;
ANTIFUNGAL AGENTS;
BETA-GLUCANS;
BIOLOGICAL MARKERS;
FUNGI;
GLUCANS;
HUMANS;
IMMUNOCOMPROMISED HOST;
INTENSIVE CARE UNITS;
LENGTH OF STAY;
MYCOSES;
RESPIRATION, ARTIFICIAL;
RISK;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 0032602465
PISSN: 09164804
EISSN: None
Source Type: Journal
DOI: 10.3314/jjmm.40.135 Document Type: Review |
|
Times cited : (3)
|
|
References (9)
|
